GlycoMimetics Profitability Analysis

GLYC Stock  USD 0.32  0.01  3.03%   
Based on GlycoMimetics' profitability indicators, GlycoMimetics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess GlycoMimetics' ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2011-12-31
Previous Quarter
-10.7 M
Current Value
-10.1 M
Quarterly Volatility
6.6 M
 
Yuan Drop
 
Covid
At present, GlycoMimetics' Days Sales Outstanding is projected to increase significantly based on the last few years of reporting. The current year's EV To Sales is expected to grow to about 11.4 K, whereas Operating Cash Flow Sales Ratio is projected to grow to (3.3 K). At present, GlycoMimetics' Non Operating Income Net Other is projected to increase significantly based on the last few years of reporting. The current year's Income Quality is expected to grow to 0.99, whereas Operating Income is forecasted to decline to (41.2 M).
For GlycoMimetics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GlycoMimetics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GlycoMimetics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GlycoMimetics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GlycoMimetics over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlycoMimetics. If investors know GlycoMimetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlycoMimetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.59)
Return On Equity
(1.04)
The market value of GlycoMimetics is measured differently than its book value, which is the value of GlycoMimetics that is recorded on the company's balance sheet. Investors also form their own opinion of GlycoMimetics' value that differs from its market value or its book value, called intrinsic value, which is GlycoMimetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlycoMimetics' market value can be influenced by many factors that don't directly affect GlycoMimetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlycoMimetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if GlycoMimetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlycoMimetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

GlycoMimetics Return On Asset vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining GlycoMimetics's current stock value. Our valuation model uses many indicators to compare GlycoMimetics value to that of its competitors to determine the firm's financial worth.
GlycoMimetics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, GlycoMimetics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GlycoMimetics' earnings, one of the primary drivers of an investment's value.

GlycoMimetics Return On Asset vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

GlycoMimetics

Return On Equity

 = 

Net Income

Total Equity

 = 
-1.04
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

GlycoMimetics

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.59
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.

GlycoMimetics Return On Asset Comparison

GlycoMimetics is currently under evaluation in return on asset category among its peers.

GlycoMimetics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in GlycoMimetics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GlycoMimetics will eventually generate negative long term returns. The profitability progress is the general direction of GlycoMimetics' change in net profit over the period of time. It can combine multiple indicators of GlycoMimetics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-39.3 M-41.2 M
Income Before Tax-36.9 M-38.7 M
Total Other Income Expense Net2.4 M2.5 M
Net Loss-36.9 M-38.7 M
Income Tax Expense(637.00)(605.15)
Net Loss-42 M-44.1 M
Net Loss-38.1 M-40 M
Non Operating Income Net Other748.9 K786.3 K
Interest Income2.2 M1.3 M
Net Interest Income2.2 M1.4 M
Change To Netincome5.4 M4.9 M
Net Loss(0.58)(0.61)
Income Quality 0.95  0.99 
Net Income Per E B T 1.80  0.98 

GlycoMimetics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on GlycoMimetics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GlycoMimetics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GlycoMimetics' important profitability drivers and their relationship over time.

GlycoMimetics Profitability Trends

GlycoMimetics profitability trend refers to the progression of profit or loss within a business. An upward trend means that GlycoMimetics' profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is GlycoMimetics' gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

GlycoMimetics Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between GlycoMimetics different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards GlycoMimetics in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down GlycoMimetics' future profitability.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in GlycoMimetics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Use Investing Themes to Complement your GlycoMimetics position

In addition to having GlycoMimetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Utilities theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether GlycoMimetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GlycoMimetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Glycomimetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Glycomimetics Stock:
Check out Risk vs Return Analysis.
For information on how to trade GlycoMimetics Stock refer to our How to Trade GlycoMimetics Stock guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
To fully project GlycoMimetics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of GlycoMimetics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include GlycoMimetics' income statement, its balance sheet, and the statement of cash flows.
Potential GlycoMimetics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although GlycoMimetics investors may work on each financial statement separately, they are all related. The changes in GlycoMimetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GlycoMimetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.